First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...
To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...
The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...
Sanofi and Roche reported fourth-quarter and full-year 2025 earnings. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat ...
The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the announcement was light on details.
Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work requirements, the Trump administration announced Thursday, signaling how ...
This week on "The Readout LOUD": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high ...
Senators call for a review of TrumpRx by the Office of Inspector General at the Department of Health and Human Services.
How big of a role do our genes play in our lifespan? Quite a bit more than previously thought, a new study suggests.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...
Trump wants lawmakers to force pharma companies to lower their prices, but it's not clear the GOP is on board.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results